The 2020 Worldwide Pharma & Biotech Industry R&D Scene
Infographic Of R&D KPIs
INFOGRAPHIC: A snapshot of the industry in key performance indicators, taken in early 2020.
You may also be interested in...
Join us for a quick audio roundup of five useful things to know from Scrip’s recent coverage of the global biopharmaceutical industry.
Further competition to Sanofi/Regeneron’s Dupixent in nasal polyps is on the horizon but the newcomers will have some catching up to do.
A 39% relative risk reduction in the primary endpoint for the DAPA-CKD study and a 31% reduction in all-cause mortality prime Farxiga for a new chronic kidney disease indication following filings due in the next few months.